ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, ShockWave Medical, Inc. (SWAV) shows an Average True Range (ATR) of 1.53 and an Enterprise Value of 12.77B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into SWAV's underlying financial health and market activity.
ShockWave Medical, Inc. (SWAV) technical indicators as of July 20, 2025: the SMA 20 is 0.95%, SMA 50 at 2.97%, and SMA 200 at 39.16%. The RSI 14 value is 77.63, suggesting its current momentum. These technical analysis signals help assess SWAV's price trends and potential future movements.
ShockWave Medical, Inc. (SWAV) stock performance overview as of July 20, 2025: The 52-week high is N/A (currently -0.04% below), and the 52-week low is N/A (currently 113.22% above). Over the past year, SWAV's performance is 20.03%, compared to the S&P 500's 13.57% change.
According to market data, ShockWave Medical, Inc. (SWAV) stock's recent performance metrics show that over the last month, SWAV is 1.37%, with a Year-to-Date (YTD) performance of 75.55%. Over the past year, the stock has seen a 20.03% change. These figures summarize SWAV's price movements across various periods, reflecting its historical returns.
According to current financial data, SWAV stock's P/E (TTM) ratio is 125.25, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SWAV, including P/S (29.80), P/B (16.60), and P/FCF (138.06), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.